Method for preparing medicine with dicaffeoylquinic acid for treating gout

    公开(公告)号:US20200000761A1

    公开(公告)日:2020-01-02

    申请号:US16566886

    申请日:2019-09-11

    IPC分类号: A61K31/216

    摘要: 1,4-dicaffeoylquinic acid is used as a xanthine oxidase inhibitor and in preparation of a medicament for treating gout. The present invention is the first to isolate and identify a dicaffeoylquinic acid compound from Artemisia selengensis leaves. The compound not only has an ability of inhibiting xanthine oxidase activity, but also has the function of anti-gout inflammation, which can be better used for treating gout. The dicaffeoylquinic acid is derived from natural plants and has the advantages of being safe and non-toxic, and having fewer side effects.

    Method for preparing medicine with dicaffeoylquinic acid for treating gout

    公开(公告)号:US11020367B2

    公开(公告)日:2021-06-01

    申请号:US16566886

    申请日:2019-09-11

    IPC分类号: A61K31/216

    摘要: 1,4-dicaffeoylquinic acid is used as a xanthine oxidase inhibitor and in preparation of a medicament for treating gout. The present invention is the first to isolate and identify a dicaffeoylquinic acid compound from Artemisia selengensis leaves. The compound not only has an ability of inhibiting xanthine oxidase activity, but also has the function of anti-gout inflammation, which can be better used for treating gout. The dicaffeoylquinic acid is derived from natural plants and has the advantages of being safe and non-toxic, and having fewer side effects.